Account
Insider Insights
23.06.2022
AIFA reorganisation delayed again

It is widely expected that the reform will entail the unification of the CTS and the CPR into one bo...

Read more
Insider Insights
21.06.2022
Sweden TLV considers cost containment measures

According to the TLV, “The prices of medicines that have been on the market between 5 and 15 years...

Read more
Insider Insights
20.06.2022
NICE trials new proportionate approach to increase

The aim of this trial is to increase capacity, with a goal of a 20% increase by 2023-24.

Read more
Insider Insights
15.06.2022
NHS announces further details of subscription styl

The subscription-style payment model for antibiotics announced by NICE in April 2022 will be capped ...

Read more
Insider Insights
09.06.2022
UK launch of innovative medicines fund

Through the new fund, £340 million is to be made available to purchase promising, potentially life-...

Read more
Insider Insights
27.05.2022
New coalition to improve access to cancer drugs in

According to the UICC, “priority will be given to medicines currently on the WHO Essential Medicin...

Read more
Insider Insights
26.05.2022
G-BA awards highest rating to Trodelvy

The drug was judged to offer an indication of major additional benefit in adult patients with advanc...

Read more
Insider Insights
26.05.2022
New pilot project which delays reimbursement for o

Under ODAP, a protocol is drawn up “with criteria for starting, stopping and effect of a medicine....

Read more
Insider Insights
25.05.2022
Access consortium recommended by NICE in draft gui

The Access Consortium is made up of regulatory authorities including the UK, Australia, Canada, Sing...

Read more
Insider Insights
24.05.2022
Preliminary analysis of reformed early access

The High Authority for Health (HAS) and National Agency for Drug Safety (ANSM) have published a prel...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.